Tag: avodart

Quick Search


Avodart (dutasteride) & Proscar (finasteride)

Fri 1 Oct 2010

By: Mark Scholz, M.D. Prostate Oncology Specialists October 2010 Avodart® and Proscar® are FDA approved for the treatment of benign prostatic hyperplasia (BPH), the natural enlargement of the prostate that occurs with aging.  They are well-tolerated agents, except for occasional impotence or reduced libido that resolves when the treatment is stopped. Proscar and Avodart workRead More ›

What We Should Have Learned About Prostate Cancer (PC) in the Past 10 Years: Part Two

Fri 30 May 2008

by Stephen B. Strum, MD, FACP Medical Oncologist and PCRI Co-founder Ashland, OR Edited from PCRI Insights May, 2008 v 11.2 Editor’s Note: In the Part 1, Dr. Strum illustrated his thesis, “what we should have learned about PC prevention”, with a case study of the Prostate Cancer Prevention Trial (PCPT). Explanation of High-Grade PCRead More ›

The PCRI Views Regarding Testing for Prostate Cancer Using PSA as a Principal Marker

Tue 31 Aug 2004

  PCRI Insights August 2004 vol. 7, no. 3 PCRI Statement on Annual Testing for PC (The Basics) The Prostate Cancer Research Institute (PCRI) strongly supports annual testing for the early detection of prostate cancer. Effective testing combines both a prostate specific antigen (PSA) blood test and a digital rectal exam (DRE) for men, beginningRead More ›